|
HNRNPL expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.034000E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.709900E-02 |
| Normal-vs-Stage2 |
1.545800E-01 |
| Normal-vs-Stage3 |
6.117400E-01 |
| Normal-vs-Stage4 |
6.268600E-01 |
| Stage1-vs-Stage2 |
9.368400E-01 |
| Stage1-vs-Stage3 |
5.103600E-02 |
| Stage1-vs-Stage4 |
1.888840E-01 |
| Stage2-vs-Stage3 |
1.315980E-01 |
| Stage2-vs-Stage4 |
1.716850E-01 |
| Stage3-vs-Stage4 |
9.904400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.291400E-01 |
| Normal-vs-AfricanAmerican |
5.931000E-01 |
| Normal-vs-Asian |
6.382000E-01 |
| Caucasian-vs-AfricanAmerican |
3.889800E-01 |
| Caucasian-vs-Asian |
8.622600E-01 |
| AfricanAmerican-vs-Asian |
8.968600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.947600E-02 |
| Normal-vs-Female |
9.484400E-01 |
| Male-vs-Female |
5.494300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.225200E-01 |
| Normal-vs-Extreme_Weight |
6.334400E-02 |
| Normal-vs-Obese |
8.223200E-01 |
| Normal-vs-Extreme_Obese |
2.427600E-02 |
| Normal_Weight-vs-Extreme_Weight |
4.150200E-01 |
| Normal_Weight-vs-Obese |
2.996600E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.639390E-01 |
| Extreme_Weight-vs-Obese |
3.843800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.478400E-01 |
| Obese-vs-Extreme_Obese |
5.298300E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.884960E-01 |
| Normal-vs-Age(41-60Yrs) |
8.204600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.098080E-02 |
| Normal-vs-Age(81-100Yrs) |
2.609900E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.338600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.501600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.837700E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.566600E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.254400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.460600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.034400E-01 |
| Normal-VS-Type2 PRCC |
6.361000E-03 |
| Normal-VS-KIRP CIMP |
2.514200E-02 |
| Normal-VS-Unclassified PRCC |
2.724200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.121500E-03 |
| Type1 PRCC-VS-KIRP CIMP |
2.198100E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.146200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.953000E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.207210E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.078350E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.538190E-02 |
| Normal-vs-N1 |
7.402100E-02 |
| Normal-vs-N2 |
7.914200E-01 |
| N0-vs-N1 |
1.847410E-04 |
| N0-vs-N2 |
2.066200E-01 |
| N1-vs-N2 |
5.522200E-01 |
|
|
